InvestorsHub Logo
Followers 149
Posts 17898
Boards Moderated 0
Alias Born 04/12/2012

Re: None

Thursday, 04/12/2018 9:47:11 AM

Thursday, April 12, 2018 9:47:11 AM

Post# of 5873
ImmunoCellular: Milestone Represents Next Important Step in Validating the Stem-to-T-Cell Approach, Is a Key Component of the Proof-Of-Concept Work for This Technology >IMUC
DOW JONES & COMPANY, INC. 4:02 AM ET 4/12/2018

(MORE TO FOLLOW) Dow Jones Newswires (212-416-2800)
04-12-180602ET
Copyright (c) 2018 Dow Jones & Company, Inc.